MEDIQON Group AG (CHG) AI Stock Analysis

• Market Cap: €925.08M
• Dividend Yield: N/A
• Average Volume (3M): 26.38K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.43
• Revenue Growth: 51.05%
• EPS Growth: -242.58%
• Country: DE
• Employees: 800
• Sector: Technology
• Sector Strength: 88
• Industry: Information Technology Services
• EPS (TTM): -0.69
• Shares Outstanding: 23,842,152
• 10 Day Avg. Volume: 27,625
• 30 Day Avg. Volume: 26,381
• PEG Ratio: -0.40
• Price to Book (P/B): 2.59
• Price to Sales (P/S): 5.28
• P/FCF Ratio: 83.86
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Hold
• Number of Analyst Covering: 0

• Rating: 45 Neutral
• Price Target: €37.00 ▼(-1.07% Downside)

The overall stock score for MEDIQON Group AG is primarily influenced by its financial performance, which shows strong revenue growth but significant profitability challenges. Technical analysis indicates a lack of strong momentum, while valuation is negatively impacted by the company's unprofitability and lack of dividend yield. The absence of earnings call data and corporate events means these factors do not influence the score.

MEDIQON Group AG Business Overview & Revenue Model

Company Description

CHAPTERS Group AG, together with its subsidiaries, provides software solutions in the DACH region. It also provides building cleaning and related services; electronic gate and door systems, as well as barriers, fire, and smoke protection systems; CAD/CAM software solutions; conversation-oriented language courses; communication design degree; pest control services; software solutions to sheet metal processing, property management, property developers, and project development industries, as well as engages in planning, consultation, and construction in the field of refrigeration and air conditioning technology, and air purification. In addition, the company provides software solutions for managing fire brigades, as well as mountain, water, and cave rescues; winKITA software; software for utilities and heating bills for private landlords and property managers; industry solutions for property developers; supplemental alarming solutions for fire brigades, rescue services, and emergency organizations; and corporate and group planning, and business intelligence solutions. Further, it offers enterprise content management software solutions; business management solutions for builders and project developers; solutions for property management companies; orchestra management software; modular software solutions; school administration software; ERP software; broadband networks for municipal utilities, municipalities, and other network owners; technical solutions; and support services for international students and young professionals, as well as imports and distributes cable protection products. Additionally, the company develops and sells software solution for fishing, hunting, and gun license administration; and provides CRM software solution to electricity and gas suppliers, water and energy suppliers, and public service broadcasters. The company was formerly known as MEDIQON Group AG and changed its name to CHAPTERS Group AG in July 2023. CHAPTERS Group AG was founded in 1998 and is based in Hamburg, Germany.

How the Company Makes Money

MEDIQON Group AG generates revenue through multiple streams, including the sale of medical devices, subscription fees for its digital health applications, and service agreements with healthcare institutions. The company leverages partnerships with hospitals and clinics to integrate its technology into existing healthcare infrastructures, which helps to secure long-term contracts and recurring revenue. Additionally, MEDIQON Group AG may benefit from research and development collaborations with pharmaceutical companies, further diversifying its income sources.

MEDIQON Group AG Financial Statement Overview

Summary

MEDIQON Group AG shows strong revenue growth but struggles with profitability, as indicated by negative net profit and EBIT margins. Improved leverage management is noted, but ROE remains negative. Positive free cash flow growth is a good sign, though cash flow efficiency needs further analysis.

Income Statement

MEDIQON Group AG has shown strong revenue growth of 27.02% in the latest year, indicating a positive trajectory. However, the company is struggling with profitability, as evidenced by negative net profit and EBIT margins. The gross profit margin has decreased significantly from the previous year, suggesting potential challenges in cost management or pricing strategy.

Balance Sheet

The company's debt-to-equity ratio has improved over the years, indicating better leverage management. However, the return on equity remains negative, reflecting ongoing challenges in generating profits from shareholders' equity. The equity ratio is stable, suggesting a balanced capital structure.

Cash Flow

MEDIQON Group AG has achieved positive free cash flow growth, which is a positive sign for liquidity. However, the operating cash flow to net income ratio is not available, limiting insights into cash flow efficiency. The free cash flow to net income ratio is also unavailable, which could provide further clarity on cash generation relative to earnings.

Breakdown	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	110.67M	70.77M	42.07M	28.66M	1.08M
Gross Profit	47.02M	8.38M	6.84M	12.26M	360.69K
EBITDA	16.35M	11.96M	4.82M	7.16M	-1.33M
Net Income	-11.47M	-4.08M	-5.88M	-2.27M	-2.27M
Balance Sheet
Total Assets	353.74M	223.95M	169.28M	103.55M	49.81M
Cash, Cash Equivalents and Short-Term Investments	58.51M	50.84M	26.28M	11.09M	614.04K
Total Debt	73.60M	69.35M	62.09M	51.70M	25.00M
Total Liabilities	128.75M	99.87M	77.11M	61.71M	41.55M
Stockholders Equity	224.99M	126.06M	93.76M	42.57M	10.00M
Cash Flow
Free Cash Flow	6.96M	3.81M	3.67M	1.15M	-1.76M
Operating Cash Flow	11.47M	7.37M	5.69M	2.87M	-1.76M
Investing Cash Flow	-98.82M	-36.34M	-53.21M	-47.40M	-5.21M
Financing Cash Flow	89.00M	48.15M	58.78M	47.06M	7.22M

MEDIQON Group AG Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 37.40
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For DE:CHG, the sentiment is Negative. The current price of 37.4 is below the 20-day moving average (MA) of 37.70, below the 50-day MA of 37.85, and below the 200-day MA of 37.50, indicating a bearish trend. The MACD of -0.19 indicates Negative momentum. The RSI at 47.74 is Neutral, neither overbought nor oversold. The STOCH value of 40.80 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for DE:CHG.

MEDIQON Group AG Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
GFT	―	€492.30M	12.71	15.59%	2.88%	5.12%	-20.33%
NA9	―	€647.20M	15.41	20.97%	2.09%	5.36%	-24.91%
D6H	―	€529.85M	21.63	15.66%	1.56%	11.88%	-3.36%
COK	―	€776.85M	41.75	3.11%	4.11%	-0.29%	-48.23%
Sector *	―	$37.18B	12.37	-10.20%	1.83%	8.50%	-7.62%
ADN1	―	€611.69M	49.89	6.72%	0.80%	12.68%	―
CHG	―	€925.08M	―	-12.43%	―	51.05%	-242.58%